56 Pharmaceutical Technology DECEMBER 2004 Cynthia K. Brown is the head of analytical development in pharmaceutical product research and development at Eli Lilly and Company. Hitesh P. Chokshi, PhD, is a research director in pharmaceutical and analytical R&D at Hoffmann-La Roche Inc. Beverly Nickerson, PhD, is an associate research fellow in analytical research and development at Pfizer Inc., E...

In this paper, we describe the evaluation of a real-world awareness (RWA) prototype designed to help managers perform environmental scanning in the pharmaceutical industry. RWA in the pharmaceutical industry consists of not only the tracking and tracing of drugs but also of pattern recognition for relevant events – both internal and external to the company which can affect a company’s drug rese...

Iran`s pharmaceutical products market as one of the major markets of the country has been faced with fluctuations over time. Suitable market selection is necessary for stability of pharmaceutical exports. Study of the global market structure of this product leads to policy makers in development, production, and trade of pharmaceuticals and finally increases country’s share of the world pharmace...

The costs of developing the types of new drugs that have been pursued by traditional pharmaceutical firms have been estimated in a number of studies. However, similar analyses have not been published on the costs of developing the types of molecules on which biotech firms have focused. This study represents a first attempt to get a sense for the magnitude of the R&D costs associated with the di...

Health is a global concern and all stakeholders in society--including the pharmaceutical industry--have an ethical responsibility to contribute to promote health. At Novo Nordisk, we have decided to focus on defeating diabetes since this is the area where the company can make the biggest difference. Financial viability goes hand in hand with environmental and social responsibility, not only in ...